Stockscreener 앱 받기
16.51
1.32%
-0.22
시간 외 거래:
16.50
-0.01
-0.06%
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Aurinia Pharmaceuticals plots early exit from Montgomery County lease following leadership overhaul - The Business Journals
Aurinia Pharmaceuticals stock heads toward its November 3 report - AD HOC NEWS
Aurinia reports second-quarter profit growth: what it means for Aurinia Pharmaceuticals stock - AD HOC NEWS
Aurinia: Lupkynis Is A Cash Cow, But Competition And Patent Risks Cap The Upside (AUPH) - Seeking Alpha
Aurinia’s (AUPH) Profits Surge While Its One Drug Just Got Company - finance.yahoo.com
Tax-withholding stock sale by Aurinia Pharmaceuticals (AUPH) legal chief - Stock Titan
Aurinia Pharmaceuticals Stock Price Forecast. Should You Buy AUPH? - StockInvest.us
Responsive Playbooks and the AUPH Inflection - Stock Traders Daily
LB Pharmaceuticals Names Joseph M. Miller as CFO, Details Compensation and Severance Package - kalkinemedia.com
LB Pharmaceuticals Inc Announces Appointment of Joseph M. Miller to Chief Financial Officer, Effective September 2, 2026 - marketscreener.com
A finance executive who helped launch a lupus drug joins LB Pharmaceuticals - Stock Titan
Is Aurinia Pharmaceuticals (AUPH) Still Below Fair Value After A 60% Rise? - simplywall.st
Kezar Life Sciences stock in focus after Aurinia tender offer and merger terms surface - AD HOC NEWS
Investors - Aurinia Pharmaceuticals Inc.
Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)? - Yahoo Finance
Aurinia Pharmaceuticals Chief Legal Officer Trades $355K In Company Stock - Benzinga
ILJIN group pushes Aurinia (NASDAQ: AUPH) stake under 5% after share sales - Stock Titan
Aurinia Pharmaceuticals (AUPH) Is Up 8.4% After Teva Agrees To Delay Generic Voclosporin Launch - webull.com
Aurinia (NASDAQ: AUPH) legal chief sells shares to cover taxes - Stock Titan
Aurinia (AUPH) Quarterly Results: EPS Clears the Reported Estimate at the Close; Market Response: The Share Price Sheds 0.48% in the Available RecordGuidance Update - vinanet.vn
Aurinia (AUPH) Market: Falls 3.59% to $16.65 at the Close; Technical Setup: $15.82 and $17.48 Define the Nearby Reference Levels on the DayBuyback Factor - siam.in
Aurinia (AUPH) Market: Falls 3.59% to $16.65 at the Close; Technical Setup: $15.82 and $17.48 Define the Nearby Reference Levels on the DayTechnical Analysis - vinanet.vn
Aurinia (NASDAQ: AUPH) officer to sell 47,000 shares for taxes - Stock Titan
Teva and Aurinia settle generics dispute over lupus drug, voclosporin - Life Sciences IP Review
Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates - Eastern Progress
Zacks Investment ResearchGlobes - Globes - Israel Business News
Aurinia Secures Lupkynis Exclusivity Through 2036 in Teva Patent Settlement - finance.biggo.com
Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises - Yahoo Finance UK
Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises - Zacks Investment Research
Bloom Burton Upgrades Aurinia Pharmaceuticals(AUPH.US) to Buy Rating, Raises Target Price to $21 - Moomoo
Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug - Benzinga
TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $17 - Moomoo
How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback - Yahoo Finance
Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises - finance.yahoo.com
Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap After A 74% Gain - Yahoo Finance
Aurinia Pharmaceuticals and Teva Pharmaceuticals Resolve Patent Litigation Over Generic Voclosporin Capsules - Kalkine Media
AUPH Stock Rallies 6% After-Hours — Here’s Why - TradingView
AUPH Stock Rallies 6% After-Hours — Here’s Why - Stocktwits
Aurinia Settles Patent Lawsuit With Teva; Shares Rise After Hours - marketscreener.com
Aurinia settles patent dispute with Teva over generic drug By Investing.com - Investing.com Canada
Aurinia stock falls on Teva patent settlement for voclosporin By Investing.com - Investing.com Australia
Aurinia, Teva Reach Voclosporin Patent Litigation Settlement - TipRanks
Aurinia stock falls on Teva patent settlement for voclosporin By Investing.com - Investing.com Canada
Aurinia stock falls on Teva patent settlement for voclosporin - Investing.com
Aurinia settles patent dispute with Teva over generic drug - Investing.com
Aurinia settles patent dispute with Teva over generic drug By Investing.com - Investing.com India
Aurinia Settles Patent Litigation with Teva - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
Aurinia (AUPH) Latest Price Review: Rises 0.07% to $15.30 in the Current Update; Level Check: the Near-Term Reference Band Stretches From $14.54 to $16.07 under the Current SnapshotETF Outflow Streak - vinanet.vn
Aurinia (AUPH) Earnings Metrics: EPS Comes in Above Forecast in the Current Update; Trading-Day Reaction: Shares Move 0.07% UpQuarterly Profit Report - vinanet.vn
0.84%
0.34%
자본화:
|
볼륨(24시간):